To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.
Public ClinicalTrials.gov record NCT02465632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) to the Marketed Product BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5% (Valeant Pharmaceuticals, US) in the Treatment of Acne Vulgaris.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, multiple-site, placebo-controlled, parallel-group study, designed to compare the efficacy and safety of generic Clindamycin 1%/ Benzoyl peroxide 5% topical gel (Glenmark Generics, Ltd), and the marketed product BenzaClin® Topical Gel, Clindamycin 1%/ Benzoyl peroxide 5% (Valeant Pharmaceuticals, US) in the treatment of acne vulgaris.
Study identification
- NCT ID
- NCT02465632
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,100 participants
Conditions and interventions
Conditions
Interventions
- Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel Drug
- BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5% Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2015 (Type not available)
- Primary completion
- Nov 2015 (Actual)
- Completion
- Dec 2015 (Actual)
- Last update posted
- Jun 28, 2017
2015
United States locations
- U.S. sites
- 13
- U.S. states
- 6
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Glenmark Investigational Site 13 | Anaheim | California | — | — |
| Glenmark Investigational Site 6 | Long Beach | California | — | — |
| Glenmark Investigational Site 15 | Los Angeles | California | — | — |
| Glenmark Investigational Site12 | West Covina | California | — | — |
| Glenmark Investigational Site 4 | Brandon | Florida | — | — |
| Glenmark Investigational Site 1 | Miami | Florida | — | — |
| Glenmark Investigational Site 8 | Miami | Florida | — | — |
| Glenmark Investigational Site 9 | Miramar | Florida | — | — |
| Glenmark Investigational Site 2 | St. Petersburg | Florida | — | — |
| Glenmark Investigational Site 5 | Louisville | Kentucky | — | — |
| Glenmark Investigational Site7 | Upper Saint Clair | Pennsylvania | — | — |
| Glenmark Investigational Site 14 | Greenville | South Carolina | — | — |
| Glenmark Investigational Site 3 | Nashville | Tennessee | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02465632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2017 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02465632 live on ClinicalTrials.gov.